Adverse reactions following immunization with MMR vaccine in children at selected provinces of Iran

Archives of Iranian Medicine

Volumn 14, Issue 2, 2011, Pages 91-95

  Esteghamati, Abdoulreza ^a   Keshtkar, Abbasali ^b,c   Heshmat, Ramin ^c   Gouya, Mohammad Mehdi ^d   Amoli, Masoud Salar ^d   Armin, Shahnaz ^e   Mahoney, Frank ^f  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^e SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Adverse event; Iran; Measles mumps rubella vaccine

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ACTIVE IMMUNIZATION; ANAPHYLAXIS; ARTICLE; BRAIN DISEASE; CHILD; DRUG SAFETY; FEBRILE CONVULSION; HUMAN; IRAN; MAJOR CLINICAL STUDY; MEASLES; MUMPS; PAROTITIS; PATIENT ASSESSMENT; PRESCHOOL CHILD; RUBELLA; SEIZURE; VACCINATION REACTION;

ANAPHYLAXIS; CHILD; CHILD, PRESCHOOL; FEVER; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; IRAN; MEASLES-MUMPS-RUBELLA VACCINE; PAROTITIS; SEIZURES; VACCINES, COMBINED;

EID: 79952952391     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Lim FS, Han HH, Bock HL. Safety, reactogenicity and immunogenicity of the live attenuated combined measles, mumps and rubella vaccine containing the RIT 4385 mumps strain in healthy Singaporean children. Ann Acad Med Singapore. 2007; 36: 969-973.
2. Makino S, Sasaki K, Nakayama T, Oka S, Urano T, Kimura M, et al. A new combined trivalent live measles (AIK-C strain), mumps (Hoshino strain), and rubella (Takahashi strain) vaccine. Am J Dis Child. 1990; 144: 905-910.
3. Redd SC, Markowitz LE, Katz SL. Measles vaccine. In: Plotkin SA, Orenstein WA, Offit PA, eds. Vaccines. 3rd ed. Philadelphia: W. B. Saunders Company; 1999: 222-265.
4. Loo MK, Sabahi F, Soleimanjdahi H, Kazemnejad A, Roustai MH. Seroprevalence of neutralizing antibodies to measles virus in a vaccinated population in Iran, 1998. Eur J Epidemiol. 2003; 18: 1085-1089.
5. Al-Mazrou Y, Tumsah S, Khalil M, Al-Jeffri M, Afzal MA, al- Ghamdy Y, et al. Safety evaluation of MMR vaccine during a primary school campaign in Saudi Arabia. J Trop Pediatr. 2002; 48: 354-358.
6. Jefferson T, Price D, Demicheli V, Bianco E. Unintended events following immunization with MMR: a systematic review. Vaccine. 2003; 21: 3954-3960.
7. Gooya MM, Zahraee SM, Esteghamati AR, Salaramoli M, Abdolo F, Babaee A. Expanded Program on Immunization. Health Ministry, Tehran, Iran; 2004.
8. Department of Vaccines and Biologicals WHO. Supplementary Information on Vaccine Safety, Part 2: Background Rates of Adverse Events Following Immunization. Geneva: WHO; 2000.
9. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull World Health Organ. 1999; 77: 3-14.
10. Slater PE, Roitman M, Costin C. Mumps incidence in Israel-- impact of MMR vaccine. Public Health Rev. 1990; 18: 88-93.
11. Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001; 345: 656-661.
12. Patja A, Davidkin I, Kurki T, Kallio MJ, Valle M, Peltola H. Serious adverse events after measles-mumps-rubella vaccination during a fourteen-year prospective follow-up. Pediatr Infect Dis J. 2000; 19: 1127-1134.
13. Weibel RE, Caserta V, Benor DE, Evans G. Acute encephalopathy followed by permanent brain injury or death associated with further attenuated measles vaccines: a review of claims submitted to the National Vaccine Injury Compensation Program. Pediatrics. 1998; 101: 383-387.
14. Davis RL, Barlow W. Placing the risk of seizures with pediatric vaccines in a clinical context. Paediatr Drugs. 2003; 5: 717-722.
15. Griffin MR, Ray WA, Mortimer EA, Fenichel GM, Schaffner W. Risk of seizures after measles-mumps-rubella immunization. Pediatrics. 1991; 88: 881-885.
16. D'Souza RM, Campbell-Lloyd S, Isaacs D, Gold M, Burgess M, Turnbull F, et al. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign. Commun Dis Intell. 2000; 24: 27-33.